⌘K
Loading ticker…
Anixa Biosciences, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Anixa Biosciences, Inc. (ANIX) has a 3-month relative strength percentile of 52 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.7%, relative volume 5.68×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
52 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ANIX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $875K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANIX Jan avg: 10.57% median: 9.92% win: 75% σ: 12.68% n: 4 2022-04-12 → 2026-05-29 | ANIX Feb avg: -3.78% median: -0.41% win: 50% σ: 13.51% n: 4 2022-04-12 → 2026-05-29 | ANIX Mar avg: -9.05% median: -10.03% win: 0% σ: 4.57% n: 4 2022-04-12 → 2026-05-29 | ANIX Apr avg: 5.78% median: -2.45% win: 40% σ: 13.95% n: 5 2022-04-12 → 2026-05-29 | ANIX May avg: -10.12% median: -10.00% win: 20% σ: 13.37% n: 5 2022-04-12 → 2026-05-29 | ANIX Jun avg: 2.29% median: -2.24% win: 50% σ: 19.21% n: 4 2022-04-12 → 2026-05-29 (current) | ANIX Jul avg: 19.83% median: 18.19% win: 75% σ: 24.05% n: 4 2022-04-12 → 2026-05-29 | ANIX Aug avg: 2.57% median: 1.42% win: 75% σ: 5.13% n: 4 2022-04-12 → 2026-05-29 | ANIX Sep avg: 2.94% median: 2.34% win: 50% σ: 13.51% n: 4 2022-04-12 → 2026-05-29 | ANIX Oct avg: 11.68% median: 12.47% win: 75% σ: 11.73% n: 4 2022-04-12 → 2026-05-29 | ANIX Nov avg: 0.28% median: -0.01% win: 50% σ: 9.81% n: 4 2022-04-12 → 2026-05-29 | ANIX Dec avg: -15.31% median: -22.69% win: 25% σ: 22.19% n: 4 2022-04-12 → 2026-05-29 |